FeesSafety
Pluang+

Bitcoin's current bear market is milder than past crashes, signaling potential resilience amid AI investment shifts.

Market News
19 Aug 2026
Crypto news
View Source
Neutral
Bitcoin's current bear market is milder than past crashes, signaling potential resilience amid AI investment shifts.

Bitcoin has experienced a bear market with a decline of about 49% from its October 2025 peak, which is less severe than previous drops of 75% to 80%. SkyBridge Capital's Anthony Scaramucci suggests this smaller drawdown may indicate a stronger buyer base preparing for recovery. The subdued price is partly due to capital shifting from cryptocurrencies to artificial intelligence investments. Scaramucci forecasts Bitcoin could surpass $100,000 after the next halving in 2028 but cautions that the market may stay sideways for a while. Despite this optimism, experts note that the bear market is not over and Bitcoin remains nearly 50% below its all-time high, with market volatility and economic factors still influencing price movements.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
13 minutes ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
13 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Nanobiotix reports promising Phase 1 results for JNJ-1900 in resistant melanoma with 41.7% response rate

Nanobiotix reports promising Phase 1 results for JNJ-1900 in resistant melanoma with 41.7% response rate

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3) combined with immune checkpoint inhibitors in 24 patients with advanced primary cutaneous melanoma resistant to anti-PD-1 therapy. The treatment showed a 41.7% overall response...

Company Fundamentals
Bullish
4 hours ago
NEAR Protocol to hold Q3 Backers Summit on Oct 28 covering tokenomics, AI, and House of Stake proposal.

NEAR Protocol to hold Q3 Backers Summit on Oct 28 covering tokenomics, AI, and House of Stake proposal.

NEAR Protocol announced a Q3 Backers Summit scheduled for October 28. The event will focus on discussions about its House of Stake issuance proposal, updates on NEAR AI, and integration plans. Tokenomics and AI are key topics, with special guests exp...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App